How do you validate preservative performance for eye care (micro risk control)?

For eye care, we validate preservative performance through risk-based formula design plus preservative efficacy (challenge) testing and batch microbiological controls. We can support the testing plan, third-party reports, and documentation needed for US retailer/Amazon due diligence.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • For eye-area formulas, we start with a micro-risk assessment (water content, pH, packaging exposure) and build a preservative system accordingly, then screen it in our in-house microbiology capability (including a dedicated microbial challenge room and our patented cosmetic biochemistry incubator).
  • We do preservative efficacy (challenge) testing and microbiological limit testing, and we can also coordinate third-party testing and tracking of reports via our long-term testing collaboration with the Guangzhou cosmetics inspection lab.
  • On the documentation side, we can provide manufacturing quality-system support (ISO 9001:2015), and can support environmental/ethical positioning with REACH compliance and no-animal-testing alignment where applicable.
  • We also support barcode/label info, and can help arrange clinical testing support to substantiate safety/effectiveness claims (without implying regulatory approval).
  • Timelines: overall brand one-stop delivery is typically 45-60 days; bulk production is usually 10-20 working days once the formula and sample are confirmed.
  • Packaging sourcing often takes 10-30 working days (e.g., glass bottle ~15 days, acrylic bottle ~30 days, tube ~15 days).
  • MOQ is confirmed case-by-case after formula and packaging are locked to control risk and cost.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).